April, 2019
For breast cancer screening and colorectal cancer screening, net transportation costs fall comfortably below the conventionally accepted $50,000 quality-adjusted life year (QALY) standard.
April, 2019
For prenatal care, asthma, congestive heart failure, and diabetes, improved transportation produces net cost savings.
November, 2018
The No. 1 request for assistance that Kentucky CancerLink receives — more than 2,000 per year — is for help getting a ride to treatment.
February, 2013
Lack of access to a vehicle was associated with the underuse of chemotherapy. Even in non-rural populations, transportation barriers are associated with the underuse of chemotherapy. Given the effectiveness of modern chemotherapy for palliation and prolonged survival, patients without reliable transportation may not have lived as long as those with reliable transportation.
January, 2006
For the five preventive conditions examined (including two types of cancer screening), it was determined that the provision of increased access to NEMT for the transportation-disadvantaged population is cost-effective for all five, because projected improvements in life expectancy and quality of life are large enough to justify the net cost increases.